Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1715-30-6
2. Alexidine Hydrochloride
3. Alexidine Hcl
4. Alexidine (dihydrochloride)
5. Alexidine.dihydrochloride
6. I2a7616py1
7. Ncgc00094996-01
8. 1,1'-hexamethylenebis(5-(2-ethylhex-1-yl))biguanide Dihydrochloride
9. 1,1'-hexamethylenebis[5-(2-ethylhex-1-yl)]biguanide Dihydrochloride
10. Dsstox_cid_25881
11. Dsstox_rid_81197
12. Dsstox_gsid_45881
13. 2,4,11,13-tetraazatetradecanediimidamide, N,n''-bis(2-ethylhexyl)-3,12-diimino-, Dihydrochloride
14. 2,4,11,13-tetraazatetradecanediimidamide, N1,n14-bis(2-ethylhexyl)-3,12-diimino-, Hydrochloride (1:2)
15. 1,1-hexamethylene-bis(5-[2-ethylhexyl]biguanide)"
16. 1,1'-hexamethylenebis[5-(2-ethylhexyl)]biguanide Dihydrochloride
17. N,n''-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine Dihydrochloride
18. Prestwick_42
19. Cas-1715-30-6
20. Sr-01000838863
21. Unii-i2a7616py1
22. Alexidine 2hcl
23. Einecs 216-994-6
24. Mfcd00082369
25. Schembl292713
26. Spectrum1503074
27. Chembl554041
28. Dtxsid5045881
29. Hms1570k16
30. Hms1922c13
31. Baa71530
32. Bcp30227
33. Tox21_111380
34. Bdbm50495214
35. Ccg-39767
36. Akos024258863
37. Tox21_111380_1
38. Ncgc00094996-02
39. Ncgc00178352-06
40. Bs-50064
41. N,n''-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide Dihydrochloride
42. Alexidine Dihydrochloride, >=95% (hplc)
43. Hy-108547
44. Cs-0029119
45. Ft-0661484
46. Sw196358-4
47. J-010730
48. Sr-01000838863-2
49. Sr-01000838863-3
50. Q27280286
51. 1,1'-hexamethylenebis(5-(2-ethylhex-1-yl))biguanidedihydrochloride
52. 1-[n'-[6-[[amino-[[n'-(2-ethylhexyl)carbamimidoyl]amino]methylidene]amino]hexyl]carbamimidoyl]-2-(2-ethylhexyl)guanidine;dihydrochloride
Molecular Weight | 581.7 g/mol |
---|---|
Molecular Formula | C26H58Cl2N10 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 23 |
Exact Mass | 580.4222973 g/mol |
Monoisotopic Mass | 580.4222973 g/mol |
Topological Polar Surface Area | 178 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 601 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Alexidine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alexidine Dihydrochloride, including repackagers and relabelers. The FDA regulates Alexidine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alexidine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Alexidine Dihydrochloride supplier is an individual or a company that provides Alexidine Dihydrochloride active pharmaceutical ingredient (API) or Alexidine Dihydrochloride finished formulations upon request. The Alexidine Dihydrochloride suppliers may include Alexidine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Alexidine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alexidine Dihydrochloride written confirmation (Alexidine Dihydrochloride WC) is an official document issued by a regulatory agency to a Alexidine Dihydrochloride manufacturer, verifying that the manufacturing facility of a Alexidine Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alexidine Dihydrochloride APIs or Alexidine Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Alexidine Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Alexidine Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alexidine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alexidine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alexidine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alexidine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alexidine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alexidine Dihydrochloride suppliers with NDC on PharmaCompass.
Alexidine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alexidine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alexidine Dihydrochloride GMP manufacturer or Alexidine Dihydrochloride GMP API supplier for your needs.
A Alexidine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Alexidine Dihydrochloride's compliance with Alexidine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Alexidine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Alexidine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alexidine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Alexidine Dihydrochloride EP), Alexidine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alexidine Dihydrochloride USP).
LOOKING FOR A SUPPLIER?